Clinical trial
Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
NCT03121469 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
- Lead sponsor
- Centre Antoine Lacassagne
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 25, 2018
- Completion date
- June 10, 2025
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
localized breast cancer